- Home
- WASH vs OCS Comparison
WASH vs OCS Comparison
Compare WASH & OCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WASH
- OCS
- Stock Information
- Founded
- WASH 1800
- OCS 2003
- Country
- WASH United States
- OCS Switzerland
- Employees
- WASH N/A
- OCS N/A
- Industry
- WASH Major Banks
- OCS Biotechnology: Pharmaceutical Preparations
- Sector
- WASH Finance
- OCS Health Care
- Exchange
- WASH Nasdaq
- OCS Nasdaq
- Market Cap
- WASH 613.2M
- OCS 711.4M
- IPO Year
- WASH N/A
- OCS N/A
- Fundamental
- Price
- WASH $32.83
- OCS $22.74
- Analyst Decision
- WASH Hold
- OCS Strong Buy
- Analyst Count
- WASH 2
- OCS 5
- Target Price
- WASH $34.00
- OCS $28.80
- AVG Volume (30 Days)
- WASH 245.2K
- OCS 104.7K
- Earning Date
- WASH 01-29-2025
- OCS 03-17-2025
- Dividend Yield
- WASH 6.82%
- OCS N/A
- EPS Growth
- WASH N/A
- OCS N/A
- EPS
- WASH 2.67
- OCS N/A
- Revenue
- WASH $188,967,000.00
- OCS $1,027,571.00
- Revenue This Year
- WASH N/A
- OCS $6.21
- Revenue Next Year
- WASH $11.60
- OCS $760.04
- P/E Ratio
- WASH $12.30
- OCS N/A
- Revenue Growth
- WASH N/A
- OCS N/A
- 52 Week Low
- WASH $24.11
- OCS $10.55
- 52 Week High
- WASH $40.59
- OCS $23.08
- Technical
- Relative Strength Index (RSI)
- WASH 53.08
- OCS 86.78
- Support Level
- WASH $28.84
- OCS $21.80
- Resistance Level
- WASH $33.05
- OCS $23.08
- Average True Range (ATR)
- WASH 1.05
- OCS 0.56
- MACD
- WASH 0.39
- OCS 0.48
- Stochastic Oscillator
- WASH 94.77
- OCS 94.52
About WASH Washington Trust Bancorp Inc.
Washington Trust Bancorp Inc through its subsidiaries offers banking and financial services to individuals and businesses. It operates in two segments. The Commercial Banking segment includes lending activities, commercial loans, residential real estate loan deposit activities, and others. The Wealth Management Services segment consists of investment management, financial planning, personal trust, and estate services including services as trustee, personal representative, custodian and guardian, and settlement of decedents' estates. The bank generates a majority of its revenue from the Commercial Banking segment.
About OCS Oculis Holding AG Ordinary shares
Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.